Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial

The gut microbiota of preterm infants is affected by perinatal factors and, in turn, may impact upon infant health. In this study, we collected fecal samples at Day-10 (D10) and 4-months corrected-age (4M) from 227 moderate–late preterm (MLPT) babies enrolled in a randomized controlled trial of nutr...

Full description

Bibliographic Details
Main Authors: Clara Yieh Lin Chong, Tommi Vatanen, Tanith Alexander, Frank H. Bloomfield, Justin M. O’Sullivan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.595323/full
_version_ 1818617609512288256
author Clara Yieh Lin Chong
Tommi Vatanen
Tommi Vatanen
Tanith Alexander
Tanith Alexander
Frank H. Bloomfield
Justin M. O’Sullivan
Justin M. O’Sullivan
author_facet Clara Yieh Lin Chong
Tommi Vatanen
Tommi Vatanen
Tanith Alexander
Tanith Alexander
Frank H. Bloomfield
Justin M. O’Sullivan
Justin M. O’Sullivan
author_sort Clara Yieh Lin Chong
collection DOAJ
description The gut microbiota of preterm infants is affected by perinatal factors and, in turn, may impact upon infant health. In this study, we collected fecal samples at Day-10 (D10) and 4-months corrected-age (4M) from 227 moderate–late preterm (MLPT) babies enrolled in a randomized controlled trial of nutritional management. A total of 320 samples underwent 16S amplicon sequencing, and shotgun metagenomic sequencing was performed on 94 samples from the 4M time point. The microbiome of babies whose families lived in lower socioeconomic status (SES) areas exhibited a significantly higher microbial alpha diversity at D10 (Wilcoxon test, p = 0.021), greater abundance of Bifidobacterium (linear model, q = 0.020) at D10 and Megasphaera (q = 0.031) at 4M. Hospital of birth explained 5.2% of the observed variance in 4M samples (PERMANOVA, p = 0.038), with Staphylococcus aureus more abundant in fecal samples from babies born in Middlemore hospital (linear model, q = 0.016). Maternal antibiotic (Wilcoxon test, p = 0.013) and probiotic (p = 0.04) usage within the four-week period before sample collection was associated with a reduction in the alpha diversity of D10 samples. Infant probiotic intake explained 2.1% (PERMANOVA, p = 0.021) of the variance in the D10 microbial profile with increased Lactobacillus (linear model, q = 1.1 × 10−10) levels. At 4M, the microbiome of infants who were breastmilk fed had reduced alpha diversity when compared to non-breastmilk fed infants (Wilcoxon test, p < 0.05). Although causality cannot be inferred within our study, we conclude that in MLPT babies, maternal socioeconomic factors, as well as the perinatal medical environment and nutrition impact on the development of the newborn microbiome.
first_indexed 2024-12-16T17:08:25Z
format Article
id doaj.art-47d325ad27e74669a6b9058e69064ff3
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-16T17:08:25Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-47d325ad27e74669a6b9058e69064ff32022-12-21T22:23:29ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-03-011110.3389/fcimb.2021.595323595323Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled TrialClara Yieh Lin Chong0Tommi Vatanen1Tommi Vatanen2Tanith Alexander3Tanith Alexander4Frank H. Bloomfield5Justin M. O’Sullivan6Justin M. O’Sullivan7Liggins Institute, The University of Auckland, Auckland, New ZealandLiggins Institute, The University of Auckland, Auckland, New ZealandInfectious Disease & Microbiome Program, The Broad Institute of MIT and Harvard, Cambridge, MA, United StatesLiggins Institute, The University of Auckland, Auckland, New ZealandNeonatal Unit, Kidz First, Middlemore Hospital, Auckland, New ZealandLiggins Institute, The University of Auckland, Auckland, New ZealandLiggins Institute, The University of Auckland, Auckland, New ZealandThe Maurice Wilkins Centre, The University of Auckland, Auckland, New ZealandThe gut microbiota of preterm infants is affected by perinatal factors and, in turn, may impact upon infant health. In this study, we collected fecal samples at Day-10 (D10) and 4-months corrected-age (4M) from 227 moderate–late preterm (MLPT) babies enrolled in a randomized controlled trial of nutritional management. A total of 320 samples underwent 16S amplicon sequencing, and shotgun metagenomic sequencing was performed on 94 samples from the 4M time point. The microbiome of babies whose families lived in lower socioeconomic status (SES) areas exhibited a significantly higher microbial alpha diversity at D10 (Wilcoxon test, p = 0.021), greater abundance of Bifidobacterium (linear model, q = 0.020) at D10 and Megasphaera (q = 0.031) at 4M. Hospital of birth explained 5.2% of the observed variance in 4M samples (PERMANOVA, p = 0.038), with Staphylococcus aureus more abundant in fecal samples from babies born in Middlemore hospital (linear model, q = 0.016). Maternal antibiotic (Wilcoxon test, p = 0.013) and probiotic (p = 0.04) usage within the four-week period before sample collection was associated with a reduction in the alpha diversity of D10 samples. Infant probiotic intake explained 2.1% (PERMANOVA, p = 0.021) of the variance in the D10 microbial profile with increased Lactobacillus (linear model, q = 1.1 × 10−10) levels. At 4M, the microbiome of infants who were breastmilk fed had reduced alpha diversity when compared to non-breastmilk fed infants (Wilcoxon test, p < 0.05). Although causality cannot be inferred within our study, we conclude that in MLPT babies, maternal socioeconomic factors, as well as the perinatal medical environment and nutrition impact on the development of the newborn microbiome.https://www.frontiersin.org/articles/10.3389/fcimb.2021.595323/fullmoderate–late preterm infantsocioeconomic statusethnicitygut microbiomeearly life nutrition
spellingShingle Clara Yieh Lin Chong
Tommi Vatanen
Tommi Vatanen
Tanith Alexander
Tanith Alexander
Frank H. Bloomfield
Justin M. O’Sullivan
Justin M. O’Sullivan
Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
Frontiers in Cellular and Infection Microbiology
moderate–late preterm infant
socioeconomic status
ethnicity
gut microbiome
early life nutrition
title Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
title_full Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
title_fullStr Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
title_full_unstemmed Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
title_short Factors Associated With the Microbiome in Moderate–Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
title_sort factors associated with the microbiome in moderate late preterm babies a cohort study from the diamond randomized controlled trial
topic moderate–late preterm infant
socioeconomic status
ethnicity
gut microbiome
early life nutrition
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.595323/full
work_keys_str_mv AT clarayiehlinchong factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT tommivatanen factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT tommivatanen factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT tanithalexander factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT tanithalexander factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT frankhbloomfield factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT justinmosullivan factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial
AT justinmosullivan factorsassociatedwiththemicrobiomeinmoderatelatepretermbabiesacohortstudyfromthediamondrandomizedcontrolledtrial